Vijay Padul, PhD
Sr. Scientist – Omics
Vijay Padul is a Senior Scientist at Rhenix, who leads bioinformatics, genomics, and Next Generation Sequencing research-related activities, in the organization. He is currently working on the neoantigen cancer vaccine pipeline projects, here.
​
Vijay holds a Ph.D. in Life Sciences from TMC-ACTREC, Homi Bhabha National Institute, Navi Mumbai. His Ph.D. study focused on Cancer Genomics. Previously, Vijay has worked as Assistant Professor at graduate and post-graduate degree colleges as well.
At Rhenix, he has gained experience in scientific, operational, and administrative matters.
Stories
Summary "A phase Ib-IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma- CUSP9v3-2021"
Glioblastoma is the most common and aggressive primary malignant brain tumor in adults. Despite therapeutic interventions, glioblastoma prognosis remains very poor as most patients die…
Summary "An effective integrated grading system for meningioma tumor grading that incorporates molecular features."
Meningioma is the most common primary intracranial tumor in the United States. There are approximately 35,000 new cases diagnosed every year. meningioma has an estimated population prevalence of approximately...
Summary "Multi-omic analysis of low-grade glioma histological subtypes uncovers the significance of tumor purity."
Astrocytoma and Oligodendroglioma are the histological subtypes of glioma brain tumors. Histological classification of gliomas has been the clinical practice before the inclusion of molecular markers by the...
.jpg)
Summary "Nivolumab therapy in addition to chemotherapy improves survival in patients with resectable lung cancer."
Lung cancer is the third most common cancer in the United States. Over 80% of the total lung cancer cases belong to the type of non-small cell lung cancer (NSCLC). Among the patients diagnosed with...
Summary "A multicenter study uncovers genetic factors that may play a significant role in mice longevity."
Aging is a yet to be fully understood process where molecular, cellular, and organismal homeostasis is affected by multiple environmental and genetic factors which results in a progressive functional decline in physical...
Videos
A phase Ib-IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma- CUSP9v3-2021 | Cell talk
Glioblastoma is the most common and most aggressive primary malignant brain tumor in adults. Despite therapeutic interventions, the glioblastoma prognosis remains very poor as most patients die within 12 months after diagnosis...
Uncovering the link between chromatin activity, gene expression in myeloid cells, and Alzheimer’s disease risk | Cell talk
Alzheimer’s disease (AD) is a progressive neurological disorder commonly affecting people older than 65 years of age. The neurodegenerative progression of the disorder causes the death of the brain cells which results in brain atrophy...
An effective integrated grading system for meningioma tumor grading that incorporates molecular features | Cell talk
Meningioma is the most common primary intracranial tumor in the United States. There are approximately 35,000 new cases diagnosed every year. meningioma has an estimated population prevalence of approximately 1 in every...
Multi-omic analysis of low-grade glioma histological subtypes uncovers the significance of tumor purity | Cell talk
Astrocytoma and Oligodendroglioma are the histological subtypes of glioma brain tumors. Histological classification of gliomas has been the clinical practice before the inclusion of molecular markers by the World Health Organization (WHO) Classification...
Nivolumab therapy in addition to chemotherapy improves survival in patients with resectable lung cancer | Cell talk
Lung cancer is the third most common cancer in the United States. Over 80% of the total lung cancer cases belong to the type of non-small cell lung cancer (NSCLC). Among the patients diagnosed with NSCLC, ~20 to 25% have resectable cancer. Patients with...
A multicenter study uncovers genetic factors that may play a significant role in mice longevity | Cell talk
Aging is a yet to be fully understood process where molecular, cellular, and organismal homeostasis is affected by multiple environmental and genetic factors which results in a progressive functional decline in physical, mental, and reproductive...
Genomics: Can it answer longevity questions | Cell talk
Historically the attainment of healthy human longevity has remained a distant dream. With the advent of whole genome sequencing technology, an entire genetic blueprint of the human can be elucidated in a short time. The increased resolution...
Health informatics: Health and genetics data to predict longevity | Cell talk
The desire to live a healthy long life has been a constant drive in search of solutions to achieve human longevity. With the advancement in medical science, successful treatment, and management of a large number of diseases has become...
Inherited components of longevity | Cell talk
Aging and longevity has a strong genetic component. Every living organism is born with a set of genetic material that constitutes its genome. Humans inherit their genome and associated genetic traits from their parents.
A multi-omic study identifies high confidence genes implicated in biological aging | Cell talk
Aging-related degenerative diseases are the leading cause of death in developed nations. Current medical interventions are aimed at delaying the onset or treating the symptoms of individual age-related diseases. Alternative approach...
